1. Home
  2. GBIO vs WFCF Comparison

GBIO vs WFCF Comparison

Compare GBIO & WFCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • WFCF
  • Stock Information
  • Founded
  • GBIO 2016
  • WFCF 1996
  • Country
  • GBIO United States
  • WFCF United States
  • Employees
  • GBIO N/A
  • WFCF N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • WFCF Computer Software: Prepackaged Software
  • Sector
  • GBIO Health Care
  • WFCF Technology
  • Exchange
  • GBIO Nasdaq
  • WFCF Nasdaq
  • Market Cap
  • GBIO 64.8M
  • WFCF 64.6M
  • IPO Year
  • GBIO 2020
  • WFCF 2011
  • Fundamental
  • Price
  • GBIO $0.78
  • WFCF $12.31
  • Analyst Decision
  • GBIO Strong Buy
  • WFCF
  • Analyst Count
  • GBIO 2
  • WFCF 0
  • Target Price
  • GBIO $6.50
  • WFCF N/A
  • AVG Volume (30 Days)
  • GBIO 649.2K
  • WFCF 3.4K
  • Earning Date
  • GBIO 03-05-2025
  • WFCF 02-13-2025
  • Dividend Yield
  • GBIO N/A
  • WFCF N/A
  • EPS Growth
  • GBIO N/A
  • WFCF 13.22
  • EPS
  • GBIO N/A
  • WFCF 0.36
  • Revenue
  • GBIO $18,582,000.00
  • WFCF $25,815,000.00
  • Revenue This Year
  • GBIO $212.74
  • WFCF N/A
  • Revenue Next Year
  • GBIO N/A
  • WFCF N/A
  • P/E Ratio
  • GBIO N/A
  • WFCF $34.60
  • Revenue Growth
  • GBIO 514.08
  • WFCF 5.38
  • 52 Week Low
  • GBIO $0.72
  • WFCF $9.76
  • 52 Week High
  • GBIO $4.65
  • WFCF $13.85
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 29.26
  • WFCF 49.10
  • Support Level
  • GBIO $0.72
  • WFCF $12.00
  • Resistance Level
  • GBIO $1.00
  • WFCF $12.88
  • Average True Range (ATR)
  • GBIO 0.07
  • WFCF 0.55
  • MACD
  • GBIO -0.00
  • WFCF -0.06
  • Stochastic Oscillator
  • GBIO 18.68
  • WFCF 55.30

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.

Share on Social Networks: